Cited by 71Retinal Diseases and TreatmentsCholesterol and Lipid MetabolismRetinal Development and Disorders

The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit

Open access
Kliffen, M.·2000·British Journal of Ophthalmology

Abstract

AIM: To investigate the APO(*)E3-Leiden mouse as an animal model for age related maculopathy (ARM) related extracellular deposits. METHODS: Eyes were obtained from APO(*)E3-Leiden transgenic mice on a high fat/cholesterol (HFC) diet (n=12) or on a normal mouse chow (n=6), for 9 months. As controls, eyes were collected from APO-E knockout mice on the same diets. From each mouse one eye was processed for microscopic evaluation and immunohistochemistry with a polyclonal antibody directed against human apo-E. Electron microscopy was also performed. RESULTS: All 12 eyes of the APO(*)E3-Leiden mice on an HFC diet contained basal laminar deposit (BLD; class 1 to class 3), whereas two of six APO(*)E3-Leiden mice on normal chow showed BLD class 1. The ultrastructural aspects of this BLD were comparable with those seen in early BLD in humans, and BLD showed immunoreaction with anti-human-apo-E antibodies. No BLD was found in any of the control mice. Drusen were not detected in any of the mice. CONCLUSION: These results indicate that APO(*)E3-Leiden mice can be used as animal model for the pathogenesis of BLD, and that a HFC diet enhances the accumulation of this deposit. Furthermore, this study supports the previously suggested involvement of dysfunctional apo-E in the accumulation of extracellular deposits in ARM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bjo.84.12.1415

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • After 9 months on a high fat/cholesterol diet, 100% of APO*E3 Leiden mice eyes have BlamD, while 33% of APO*E3 Leiden mice on a normal diet have BlamD.

    “After 9 months on a high fat/cholesterol diet, 100% of APO*E3 Leiden mice eyes have BlamD, while 33% of APO*E3 Leiden mice on a normal diet have BlamD (Kliffen et al., 2000).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. KliVen M, van der Schaft TL, Mooy CM, et al. Morphologic changes in age-related maculopathy. Microsc Res Tech 1997; 36:106-22.
  2. Van Ree JH, van den Broek WJ, van der Zee A, et al. Inacti- vation of Apo-e and Apo-c1 by two consecutive rounds of gene targeting: eVects on mRNA expression levels of gene cluster members. Hum Mol Genet 1995;4:1403-9.
  3. Lutgens E, Daemen MJAP, Kockx M, et al. Atherosclerosis in APO*E3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation 1999;99:276-83.

Cited by

Sorted by citations

Authors
Kliffen, M.
Affiliations
Erasmus MC (NL)
Corresponding author
Kliffen, M.
Venue
British Journal of Ophthalmology
Publisher
BMJ
Published
2000-12-01
Volume
84
Issue
12
Pages
1415-1419
ISSN
0007-1161 (ISSN-L)
OpenAlex
W2165816509
Cited by
71
References
43
Citations by year
2025: 2 · 2024: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 2 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 4
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • British Journal of Ophthalmology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
basal laminar deposits, age-related maculopathy, animal models, high-fat high-cholesterol diet, apolipoprotein E, drusen, retinal ultrastructure, ApoE-deficient mice
MeSH terms
Animals, Apolipoproteins E, Basement Membrane, Dietary Fats, Disease Models, Animal, Humans, Immunoenzyme Techniques, Macular Degeneration, Mice, Transgenic, Retina, Mice, Apolipoprotein E3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review